All Anti-Bribery articles – Page 20
-
BlogFresenius Medical Care reaches ‘agreement in principle’ in FCPA case
German healthcare company Fresenius Medical Care has reached an “agreement in principle” with U.S. authorities concerning an investigation into possible violations of the Foreign Corrupt Practices Act, booking charges of €224 million (U.S. $255 million) as of Dec. 31, 2018.
-
Blog
TechnipFMC: $280M is ‘probable estimate’ in global bribery settlement
U.K.-based company TechnipFMC disclosed in a regulatory filing that it has set aside $280 million, which it says is a “probable estimate” of the aggregate settlement amount with U.S., Brazilian, and French authorities in a global bribery case.
-
BlogHerbalife provides update on FCPA probe
Dietary supplement maker Herbalife in a regulatory filing provided an update on an ongoing investigation regarding the company’s compliance with the Foreign Corrupt Practices Act in China.
-
Blog
SFO faces criticism for closing Rolls-Royce, GSK cases
The U.K. Serious Fraud Office closed two long-running bribery and corruption cases against Rolls-Royce and GlaxoSmithKline—a decision that casts further doubt around the effectiveness of the SFO’s investigatory powers and makes companies question the purpose of entering a deferred prosecution agreement at all.
-
Blog
Cognizant to pay $25M to resolve FCPA violations
Cognizant Technology Solutions has agreed to pay a civil penalty of $25 million to settle charges that it violated the Foreign Corrupt Practices Act. Additionally, two former executives of Cognizant were charged for their roles in facilitating the payment of millions of dollars in a bribe to an Indian government ...
-
Blog
The Red Flag Group opens office in Paris
The Red Flag Group, a business intelligence and technology firm, announced the opening of an office in Paris in an effort to help French companies with their anti-bribery and anti-corruption compliance efforts.